HHS Fundamental Analysis - HARTE-HANKS INC

Fundamental Rating

Overall HHS gets a fundamental rating of 3 out of 10. We evaluated HHS against 100 industry peers in the Media industry. HHS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HHS has a valuation in line with the averages, but on the other hand it scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

HHS had negative earnings in the past year.

In the past year HHS has reported a negative cash flow from operations.

The reported net income has been mixed in the past 5 years: HHS reported negative net income in multiple years.

The reported operating cash flow has been mixed in the past 5 years: HHS reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -3.18%, HHS perfoms like the industry average, outperforming 46.00% of the companies in the same industry.

HHS has a Return On Equity (-13.57%) which is comparable to the rest of the industry.

With a decent Return On Invested Capital value of 6.95%, HHS is doing good in the industry, outperforming 75.00% of the companies in the same industry.

HHS had an Average Return On Invested Capital over the past 3 years of 11.42%. This is above the industry average of 7.52%.

The 3 year average ROIC (11.42%) for HHS is well above the current ROIC(6.95%). The reason for the recent decline needs to be investigated.

		Industry Rank	Sector Rank
ROA	-3.18%
ROE	-13.57%
ROIC	6.95%

ROA(3y)-0.52%

ROA(5y)1.66%

ROE(3y)13.57%

ROE(5y)N/A

ROIC(3y)11.42%

ROIC(5y)N/A

1.3 Margins

HHS's Operating Margin of 3.21% is in line compared to the rest of the industry. HHS outperforms 49.00% of its industry peers.

HHS's Operating Margin has declined in the last couple of years.

HHS has a worse Gross Margin (18.54%) than 74.00% of its industry peers.

In the last couple of years the Gross Margin of HHS has grown nicely.

		Industry Rank	Sector Rank
OM	3.21%
PM (TTM)	N/A
GM	18.54%

OM growth 3Y-16.84%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.08%

GM growth 5Y15.62%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.

The number of shares outstanding for HHS has been increased compared to 1 year ago.

Compared to 5 years ago, HHS has more shares outstanding

HHS has a worse debt/assets ratio than last year.

2.2 Solvency

HHS has an Altman-Z score of 14.49. This indicates that HHS is financially healthy and has little risk of bankruptcy at the moment.

HHS has a Altman-Z score of 14.49. This is amongst the best in the industry. HHS outperforms 96.00% of its industry peers.

HHS has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.

HHS's Debt to Equity ratio of 0.02 is amongst the best of the industry. HHS outperforms 83.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Altman-Z	14.49

ROIC/WACC0.79

WACC8.78%

2.3 Liquidity

HHS has a Current Ratio of 1.60. This is a normal value and indicates that HHS is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 1.60, HHS is in the better half of the industry, outperforming 63.00% of the companies in the same industry.

HHS has a Quick Ratio of 1.60. This is a normal value and indicates that HHS is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 1.60, HHS is in the better half of the industry, outperforming 63.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.6
Quick Ratio	1.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 89.87% over the past year.

The Revenue has decreased by -6.48% in the past year.

The Revenue has been decreasing by -3.17% on average over the past years.

EPS 1Y (TTM)89.87%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-103.55%

Revenue 1Y (TTM)-6.48%

Revenue growth 3Y-1.63%

Revenue growth 5Y-3.17%

Sales Q2Q%-14.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y131.2%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year4.05%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

HHS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

With a Price/Forward Earnings ratio of 3.33, the valuation of HHS can be described as very cheap.

Based on the Price/Forward Earnings ratio, HHS is valued cheaper than 97.00% of the companies in the same industry.

HHS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.72.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	3.33

4.2 Price Multiples

97.00% of the companies in the same industry are more expensive than HHS, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	2.26

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for HHS!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HARTE-HANKS INC

NASDAQ:HHS (8/29/2025, 4:30:01 PM)

3.6

-0.01 (-0.28%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)08-07 2025-08-07/amc

Earnings (Next)11-12 2025-11-12

Inst Owners31.9%

Inst Owner Change-2.5%

Ins Owners38.44%

Ins Owner Change1.92%

Market Cap26.68M

Analysts80

Price TargetN/A

Short Float %0.43%

Short Ratio1.05

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	3.33
P/S	0.15
P/FCF	N/A
P/OCF	N/A
P/B	1.2
P/tB	1.24
EV/EBITDA	2.26

EPS(TTM)-0.41

EYN/A

EPS(NY)1.08

Fwd EY30.02%

FCF(TTM)-1

FCFYN/A

OCF(TTM)-0.62

OCFYN/A

SpS23.61

BVpS3

TBVpS2.9

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.18%
ROE	-13.57%
ROCE	8.8%
ROIC	6.95%
ROICexc	7.51%
ROICexgc	7.61%
OM	3.21%
PM (TTM)	N/A
GM	18.54%
FCFM	N/A

ROA(3y)-0.52%

ROA(5y)1.66%

ROE(3y)13.57%

ROE(5y)N/A

ROIC(3y)11.42%

ROIC(5y)N/A

ROICexc(3y)13.82%

ROICexc(5y)N/A

ROICexgc(3y)14.26%

ROICexgc(5y)N/A

ROCE(3y)14.46%

ROCE(5y)N/A

ROICexcg growth 3Y-19.31%

ROICexcg growth 5YN/A

ROICexc growth 3Y-19.72%

ROICexc growth 5YN/A

OM growth 3Y-16.84%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.08%

GM growth 5Y15.62%

F-Score4

Asset Turnover1.84

Health

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Debt/EBITDA	0.05
Cap/Depr	64.48%
Cap/Sales	1.64%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.6
Quick Ratio	1.6
Altman-Z	14.49

F-Score4

WACC8.78%

ROIC/WACC0.79

Cap/Depr(3y)122.2%

Cap/Depr(5y)111.4%

Cap/Sales(3y)2.1%

Cap/Sales(5y)1.87%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)89.87%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-103.55%

EPS Next Y131.2%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-6.48%

Revenue growth 3Y-1.63%

Revenue growth 5Y-3.17%

Sales Q2Q%-14.22%

Revenue Next Year4.05%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-39.85%

EBIT growth 3Y-18.2%

EBIT growth 5YN/A

EBIT Next Year198.68%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-137.18%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-119.45%

OCF growth 3YN/A

OCF growth 5YN/A

HARTE-HANKS INC (HHS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens